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Available online 5 April 2018Two human induced pluripotent stem cell (iPSC) lines were generated from ﬁbroblasts of two siblings with
methylmalonic acidemia cblB type carrying mutations in theMMAB gene: c.287T➔C (p.Ile96Thr) and a splicing
loss-of-function variant c.584G➔A affecting the last nucleotide of exon 7 in MMAB (p.Ser174Cysfs*23).
Reprogramming factors OCT3/4, SOX2, KLF4 and c-MYC were delivered using a non-integrative method based
on the Sendai virus. Once established, iPSCs have shown full pluripotency, differentiation capacity and genetic
stability.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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Resource details
Methylmalonic acidemia cblB type (MMA cblB type) is an inherited
metabolic disease caused by mutations in the MMAB gene encoding
ATP:cob(I)alamin adenosyltransferase that catalyses the synthesis ofcreativecommons.org/licenses/by-nc-nd/4.0/).
144 E. Richard et al. / Stem Cell Research 29 (2018) 143–147adenosylcobalamin (AdoCbl) from cobalamin using ATP (Froese and
Gravel, 2010). Fibroblasts from two siblings carrying the mutations
c.287T➔C (p.Ile96Thr) and c.584G➔A (p.Ser174Cysfs*23) (Table 1)
were reprogrammed using the CytoTune™ iPS Reprogramming kit de-
livering the four human reprogramming factors OCT3/4, SOX2, c-MYC
and KLF4 (Takahashi et al., 2007). The iPSC lines MMAB35-FiPS4F4
(UAMi002-A) andMMAB44-FiPS4F11 (UAMi003-A) displayed a typical
round shape ESC-like morphology and growth behaviour (Fig. 1A,
Table 2) and the colonies stained positive for alkaline phosphatase ac-
tivity (Fig. 1B). The clearance of the vectors and the exogenous
reprogramming factor genes was observed by RT-PCR after 8 culture
passages (Fig. 1C). Expression of key pluripotency genes was observed
both at protein level (transcription factors OCT4, NANOG and SOX2,
and surface markers SSEA-3, SSEA-4, TRA-1-60 and TRA-1-81) by im-
munocytochemistry (Fig. 1D, Table 2) and ﬂow cytometry analysis
(Fig. 1E, Table 2), as well as at RNA level (transcription factors OCT4,
SOX2, REX1, NANOG, CRIPTO and KLF4) by qRT-PCR (Supplementary
Fig. S1A). The iPSC lines also displayed a normal karyotype (46, XX
and 46, XY) after more than twenty culture passages (Fig. 1F). The
cells also had the capacity to form derivatives of all three germ layers
(endoderm, mesoderm and ectoderm) upon embryoid body differenti-
ation (Fig. 1G, Table 2). Mycoplasma testing by a colorimetry assay re-
vealed a negative result (Supplementary Fig. S1B). We conﬁrmed the
presence of the two mutations in the iPSC lines by Sanger sequencing
(Supplementary Fig. S1C); and we also conﬁrmed by DNA ﬁngerprint-
ing analysis that the lines were derived from the patients´ ﬁbroblasts.
In addition, methylation analysis of the promoters of the pluripotency
associated genes, OCT4 and NANOG, revealed a heavy methylation in
the original ﬁbroblasts and an almost complete demethylation in the
iPSC lines (Supplementary Fig. S1D).
Materials and methods
Non-integrative reprogramming of mutant MMAB ﬁbroblasts into iPSC
The present study included available ﬁbroblasts from twoMMA cblB
patients with defects in theMMAB gene (Table 1). Experimental proto-
cols were approved by the Institutional Ethical Committee of the
Universidad Autónoma de Madrid according to Spanish and European
Union legislation, and informed consents were obtained from the legal
care-givers. Fibroblasts were reprogrammed using the CytoTune™ iPS
Reprogramming kit (Life Technologies) following the manufacturer's
instructions. iPSCs were maintained and expanded both on feeder
layers and on feeder-free layers as previously described (Alonso-
Barroso et al., 2017).
Phosphatase alkaline analysis
Phosphatase alkaline analysis was performed as previously de-
scribed (Alonso-Barroso et al., 2017).
Detection of Sendai virus genome and transgenes
After 8 passages, iPSC lines were tested for Sendai virus (SeV) resi-
dues as described (Alonso-Barroso et al., 2017). PCR was performed
using the primers indicated in Table 3 and following the instructionsTable 1
Summary of lines.
iPSC line names Abbreviation in
ﬁgures
Gender Age Et
MMAB35-FiPS4F4 (UAMi002-A) MMAB35-4 Female Died at 4 years of age Ca
MMAB44-FiPS4F11 (UAMi003-A) MMAB44-11 Male 11 years asymptomatic Caas recommended by themanufacturer. In Fig. 1 panel C: C+: transduced
cell pool at passage zero; C−: non-template control.Immunoﬂuorescence analysis
Immunoﬂuorescence analysis was performed as previously de-
scribed (Alonso-Barroso et al., 2017). In Fig. 1 scale bars: 100 μm.Flow cytometry analysis
Weanalysed the pluripotency-associatedmarker SSEA-4 by ﬂow cy-
tometry as described (Alonso-Barroso et al., 2017).Bisulﬁte sequencing
Bisulﬁte modiﬁcation of genomic DNA was performed as previously
described (Alonso-Barroso et al., 2017). Converted DNA was ampliﬁed
by PCR using primers previously published (Freberg et al., 2007) and
Immolase™ Red DNA Polymerase (Bioline). In Supplementary Fig. S1D
each horizontal row of circles represents the methylation status of
each CpG in one clone. Open circles indicate unmethylated CpG dinucle-
otides and ﬁlled circles, methylated.In vitro differentiation
iPSC colonies were ﬁrst cultured in suspension so that they form
large aggregates called embryoid bodies, and in vitro differentiation
was performed as described (Alonso-Barroso et al., 2017).Quantitative PCR analysis
Quantitative PCR analysis was carried out as described (Alonso-
Barroso et al., 2017) and the expression levels of several pluripotency
associated genes (OCT4, SOX2, REX1, NANOG, CRIPTO and KLF4) were
quantiﬁed. Primer sequences were described by Aasen et al., 2008
(Table 3).Mycoplasma detection
Cells were screened for mycoplasma contamination using a colori-
metric assay, PlasmoTest™ Mycoplasma Detection Kit (InvivoGen),
following the manufacturer's protocol. In Supplementary Fig. S1B: neg-
ative control (C−); positive control (C+).Mutation analysis
Genomic DNA from the two patients-derived ﬁbroblasts and iPSCs
was isolated using MagNA Pure Compact DNA Isolation kit and
MagNA Pure Compact instrument (Roche). Subsequently, ampliﬁcation
by PCR of theMMAB regions containing the mutations was carried out
using the primers indicated in Table 3, and ampliﬁed PCR fragments
were sequenced in an ABI3730 sequencer (Applied Biosystems).hnicity Genotype of locus Disease
ucasian c.287T➔C (p.Ile96Thr) and c.584G➔A (p.Ser174Cysfs*23) MMA cblB type
ucasian c.287T➔C (p.Ile96Thr) and c.584G➔A (p.Ser174Cysfs*23) MMA cblB type
Fig. 1. Generation and molecular and functional characterization of the iPSC lines.
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Table 2
Characterization and validation.
Classiﬁcation Test Result Data
Morphology Photography Visual record of the lines: normal Fig. 1 panel A
Phenotype Qualitative analysis Assess staining/expression of pluripotency and cell
markers: OCT4, NANOG, SOX2, SSEA-3, TRA-1-81,
SSEA-4 and TRA-1-60
Fig. 1 panel D
Quantitative analysis Assess % of positive cells for SSEA-4. MMAB35-4: 91.5%.
MMAB44-11: 99%
Fig. 1 panel E
Genotype Karyotype (G-banding) and resolution 46XX and 46XY Resolution 450–500 Fig. 1 panel F
Identity STR analysis 16 sites tested and all of them matched Submitted in archive with journal
Mutation analysis (if applicable) Sequencing c.287T➔C (p.Ile96Thr) and c.584G➔A (p.Ser174Cysfs*23) Supplementary Fig. S1 panel C
Southern Blot OR WGS Not performed
Microbiology and virology Mycoplasma Mycoplasma testing by a colorimetric assay: negative Supplementary Fig. S1 panel B
Differentiation potential Embryoid body formation Expression of smooth muscle actin, β-III-tubulin Tuj1
and α-1 fetoprotein
Fig. 1 panel G
Donor screening (optional) HIV 1 + 2 Hepatitis B, Hepatitis C Not performed No
Genotype additional info (optional) Blood group genotyping Not performed No
HLA tissue typing Not performed No
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Karyotype analysis of the iPSC lines was carried out using cells with
more than twenty culture passages which were processed using stan-
dard cytogenetic techniques as described (Alonso-Barroso et al., 2017).
DNA ﬁngerprinting analysis
DNA ﬁngerprinting analysis was performed as previously described
(Alonso-Barroso et al., 2017).
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.scr.2018.03.021.Table 3
Reagents details.
Antibodies used for immunocytochemistry
Antibody
Pluripotency markers Mouse IgG anti-OCT4
Rat IgM anti-SSEA-3
Rabbit IgG anti-SOX2
Mouse IgG anti-SSEA-4
Mouse IgM anti-TRA-1-60
Goat IgG anti-NANOG human
Mouse IgM anti-TRA-1-81
Differentiation markers Rabbit IgG anti-α-Fetoprotein
Mouse IgG anti-β-III-Tubulin Tuj1
Mouse IgG anti-α-smooth muscle actin
Secondary antibodies Alexa 555 Donkey anti-Mouse IgG
Alexa 488 Goat anti-Rat IgM
Alexa 488 Donkey anti-Rabbit IgG
Alexa 555 Donkey anti-Mouse IgG
Alexa 647 Goat anti-Mouse IgM
Alexa 647 Donkey anti-Goat IgG
Alexa 55 Donkey anti-Mouse IgM Cy3
Primers
Target Forward/reverse prim
Reverse transcription-PCR SeV genome GGATCACTAGGTGAT
KOS transgene ATGCACCGCTACGAC
KLF4 transgene TTCCTGCATGCCAGA
c-MYC transgene TAACTGACTAGCAGG
Pluripotency markers (qPCR) OCT4 GGAGGAAGCTGACA
SOX2 TGCGAGCGCTGCACA
NANOG ACAACTGGCCGAAGA
CRIPTO CGGAACTGTGAGCAC
REX1 CCTGCAGGCGGAAAT
KLF4 CGAACCCACACAGGT
House-keeping genes (qPCR) GAPDH GCACCGTCAAGGCTG
Targeted mutation
analysis/sequencing (PCR)
MMAB exon 3 MMAB
exons 6-7
GCCTGGATGACAGAG
ATGGCCCTGCTGTAAcknowledgments
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er (5′-3′)
ATCGAGC/ACCAGACAAGAGTTTAAGAGATATGTATC
GTGAGCGC/ACCTTGACAATCCTGATGTGG
GGAGCCC/AATGTATCGAAGGTGCTCAA
CTTGTCG/TCCACATACAGTCCTGGATGATGATG
ACAATGAAA/GGCCTGCACGAGGGTTT
T/TCATGAGCGTCTTGGTTTTCC
ATAGCA/GGTTCCCAGTCGGGTTCAC
GATGT/GGGCAGCCAGGTGTCATG
AGAAC/GCACACATAGCCATCACATAAGG
GAGAA/GAGCGGGCGAATTTCCAT
AGAAC/AGGGATCTCGCTCCTGGAA
TGACTGTT/ATAAGGGCTGACAACCTCCGAGG CGCCATGGTCTGGTGGGTGAT/TCAGAG
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